Boston Scientific Corp (BSX)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$102.90

Buy

$103.30

arrow-up$0.40 (+0.39%)

Prices updated at 06 Jun 2025, 00:51 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
S&P 500
arrow-down-0.53%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Michael F. Mahoney
CEO
Mr. Michael F. Mahoney
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
53,000
Head office
300 Boston Scientific Way
Marlborough
United States
01752-1234
mobile
+1 508 683-4000
letter
BSXInvestorRelations@bsci.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Daniel J. Brennan
Executive Vice President and Chief Financial Officer
0.84m
Mr. Jonathan R. Monson
Senior Vice President, Investor Relations
-
Mr. David C. Habiger
Independent Director
-
Mr. Edward J. Ludwig
Lead Independent Director
0.16m
Mr. David S. Wichmann
Independent Director
0.15m
Ms. Ellen M. Zane
Independent Director
0.14m
Mr. Yoshiaki Fujimori
Independent Director
0.14m
Senator John E. Sununu
Independent Director
0.14m
Mr. Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiology
0.84m
Mr. Michael F. Mahoney
Chairman of the Board, President and Chief Executive Officer
1.40m
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
-
Mr. Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
0.68m
Dr. Cheryl B. Pegus, M.D.
Independent Director
0.08m
Mr. John Bradley Sorenson
Executive Vice President, Global Operations
-
Mr. Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
0.71m
Dr. Jessica L. Mega, M.D.,M.P.H.
Independent Director
0.12m
Ms. Susan E. Morano
Independent Director
0.12m
Ms. Miriam O’Sullivan
Senior Vice President and Chief Human Resources Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc141,671,066
Vanguard Group Inc134,588,729
FMR Inc128,597,214
Fidelity Management and Research Company128,597,214
Fidelity Management & Research Company LLC95,070,219

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
03 Dec 2024-
11 Feb 2025-
11 Feb 2025-
10 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
27 Nov 2024-
26 Nov 2024-
26 Nov 2024-
25 Nov 2024-
25 Nov 2024-
25 Nov 2024-
25 Nov 2024-
25 Nov 2024-
25 Nov 2024-
21 Nov 2024-
12 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.